These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 227800)

  • 21. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marek's disease--the disease and its prevention by vaccination.
    Biggs PM
    Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outbreak in three-yellow chickens with clinical tumors of high mortality caused by the coinfection of reticuloendotheliosis virus and Marek's disease virus: a speculated reticuloendotheliosis virus contamination plays an important role in the case.
    Shi M; Li M; Wang P; Wang W; Li H; Gao Y; Lin L; Huang T; Wei P
    Poult Sci; 2021 Jan; 100(1):19-25. PubMed ID: 33357681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precipitating antibody development in chicks experimentally infected with herpes virus of turkey and Marek's disease virus.
    Rana UV; Negi SK
    J Commun Dis; 1986 Mar; 18(1):13-6. PubMed ID: 3018071
    [No Abstract]   [Full Text] [Related]  

  • 29. Turkey herpesvirus and Marek's disease virus. A comparative appraisal.
    Prasad LB
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):335-58. PubMed ID: 228905
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity in the immunosuppression induced by avian reticuloendotheliosis virus.
    Walker MH; Rup BJ; Rubin AS; Bose HR
    Infect Immun; 1983 Apr; 40(1):225-35. PubMed ID: 6187691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notes on the mechanism of postvaccination immunity in Marek's disease.
    Yakovleva LS; Mazurenko NP
    Neoplasma; 1977; 24(4):387-94. PubMed ID: 198688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response of genetically susceptible and resistant chickens to cell-free and attenuated JM-V leukosis strain and its influence on early type II (Marek's) leukosis infection.
    Shieh HK; Sevoian M
    Poult Sci; 1975 Jan; 54(1):69-77. PubMed ID: 166367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trials with Marek's disease vaccines prepared from a turkey herpes virus and an attenuated Marek's disease virus.
    Blaxland JD; Macleod AJ; Hall T
    Vet Rec; 1975 Jul; 97(3):50-2. PubMed ID: 168681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity to Marek's disease: where are we now?
    Haq K; Schat KA; Sharif S
    Dev Comp Immunol; 2013 Nov; 41(3):439-46. PubMed ID: 23588041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression of in vitro responsiveness to phytohemagglutinin in spleen cells cultured from chickens with Marek's disease.
    Theis GA; McBride RA; Schierman LW
    J Immunol; 1975 Sep; 115(3):848-53. PubMed ID: 168267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    Lee LF; Liu X; Witter RL
    J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.
    Murthy KK; Calnek BW
    Infect Immun; 1979 Nov; 26(2):547-53. PubMed ID: 232690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells.
    Uni Z; Pratt WD; Miller MM; O'Connell PH; Schat KA
    Vet Immunol Immunopathol; 1994 Dec; 44(1):57-69. PubMed ID: 7725630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys.
    Lee LF; Sharma JM; Nazerian K; Witter RL
    Infect Immun; 1978 Aug; 21(2):474-9. PubMed ID: 211085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.